Gilliland Jeter Wealth Management LLC Intellia Therapeutics, Inc. Transaction History
Gilliland Jeter Wealth Management LLC
- $297 Billion
- Q2 2024
A detailed history of Gilliland Jeter Wealth Management LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Gilliland Jeter Wealth Management LLC holds 212 shares of NTLA stock, worth $4,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
212Holding current value
$4,676% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
326Shares Held
88.8MCall Options Held
673KPut Options Held
865K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$256 Million2.36% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$212 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.1MShares$201 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.8MShares$106 Million3.53% of portfolio
-
State Street Corp Boston, MA4.36MShares$96.2 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.68B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...